Semper Trust’s iShares Biotechnology ETF IBB Stock Holding History

Semper Trust’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$987K	Hold	8,025	–	–	0.46%	85
2015 Q1	$919K	Hold	8,025	–	–	0.4%	95
2014 Q4	$811K	Buy	+8,025	New	+$780K	0.33%	98
2014 Q3	–	Sell	-8,025	Closed	-$688K	–	152
2014 Q2	$688K	Sell	8,025 -150	-2%	-$11.8K	0.27%	100
2014 Q1	$644K	Hold	8,175	–	–	0.26%	103
2013 Q4	$619K	Hold	8,175	–	–	0.26%	104
2013 Q3	$571K	Buy	+8,175	New	+$536K	0.26%	108

Other funds holding IBB

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

MAA

Managed Account Advisors Jersey City, New Jersey $121B AUM 7.32% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

Semper Trust's IBB Position: Q2 2015 in Review

Semper Trust held its iShares Biotechnology ETF (IBB) position steady in Q2 2015 at 8,025 shares worth $987K. The position accounts for 0.46% of the portfolio, ranked #85.

Semper Trust first reported a position in IBB in Q3 2013 and has held it in 7 quarters since. 420 funds tracked by Wall St. Rank hold IBB as of Q2 2015.

Semper Trust held 8,025 shares of iShares Biotechnology ETF worth $987K as of Q2 2015.
Semper Trust left its iShares Biotechnology ETF share count unchanged in Q2 2015.
iShares Biotechnology ETF made up 0.46% of Semper Trust's portfolio in Q2 2015, its #85 holding.
Semper Trust first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 7 quarters since.
420 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2015.

Based on Semper Trust's 13F filing for Q2 2015, filed 10 Aug 2015.